Pei Junyu, Wang Xiaopu, Xing Zhenhua, Zheng Keyang, Hu Xinqun
Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 139 Middle Renmin Road, Changsha, Hunan, 410011, China.
Department of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
ESC Heart Fail. 2021 Feb;8(1):634-643. doi: 10.1002/ehf2.13141. Epub 2020 Dec 3.
This meta-analysis aimed to determine whether coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) should be preferred in patients with severely reduced left ventricular (LV) ejection fraction.
We searched the PubMed, EMBASE, and Cochrane Library databases from the conception of the databases till 1 May 2020 for studies on patients with severely reduced LV ejection fraction undergoing CABG and PCI. The primary clinical endpoints were 30 day and long-term mortalities. The secondary endpoints were 30 day and long-term incidences of myocardial infarction (MI) and stroke, long-term cardiovascular mortality, and repeat revascularization. Eighteen studies involving 11 686 patients were analysed. Compared with PCI, CABG had lower long-term mortality [hazard ratio (HR): 0.70, 95% confidence interval (CI): 0.61-0.80, P < 0.01], cardiovascular mortality (HR: 0.60, 95% CI: 0.43-0.85, P < 0.01), MI (HR: 0.51, 95% CI: 0.36-0.72, P < 0.01), and repeat revascularization (HR: 0.32, 95% CI: 0.23-0.47, P < 0.01) risk. Significant differences were not observed for long-term stroke (HR: 1.18, 95% CI: 0.74-1.87, P = 0.49), 30 day mortality (HR: 1.18, 95% CI: 0.89-1.56, P = 0.25), and MI (HR: 0.42, 95% CI: 0.16-1.11, P = 0.08) risk. CABG was associated with a higher risk of stroke within 30 days (HR: 2.88, 95% CI: 1.07-7.77, P = 0.04). In a subgroup analysis of propensity score-matched studies, CABG was associated with a higher long-term risk of stroke (HR: 1.61, 95% CI: 1.20-2.16, P < 0.01).
Among patients with severely reduced LV ejection fraction, CABG resulted in a lower mortality rate and an increased risk of stroke.
本荟萃分析旨在确定对于左心室(LV)射血分数严重降低的患者,冠状动脉旁路移植术(CABG)或经皮冠状动脉介入治疗(PCI)哪种更具优势。
我们检索了PubMed、EMBASE和Cochrane图书馆数据库,从数据库建立至2020年5月1日,查找有关接受CABG和PCI的LV射血分数严重降低患者的研究。主要临床终点为30天和长期死亡率。次要终点为30天和长期心肌梗死(MI)及卒中发生率、长期心血管死亡率和再次血运重建。分析了18项涉及11686例患者的研究。与PCI相比,CABG的长期死亡率[风险比(HR):0.70,95%置信区间(CI):0.61 - 0.80,P < 0.01]、心血管死亡率(HR:0.60,95% CI:0.43 - 0.85,P < 0.01)、MI(HR:0.51,95% CI:0.36 - 0.72,P < 0.01)和再次血运重建(HR:0.32,95% CI:0.23 - 0.47, P < 0.01)风险更低。长期卒中(HR:1.18,95% CI:0.74 - 1.87,P = 0.49)、30天死亡率(HR:1.18,95% CI:0.89 - 1.56,P = 0.25)和MI(HR:0.42,95% CI:0.16 - 1.11,P = 0.08)风险未观察到显著差异。CABG与30天内卒中风险较高相关(HR:2.88,95% CI:1.07 - 7.77,P = 0.04)。在倾向评分匹配研究的亚组分析中,CABG与较高的长期卒中风险相关(HR:1.61,95% CI:1.20 - 2.16,P < 0.01)。
在LV射血分数严重降低的患者中,CABG导致较低的死亡率,但卒中风险增加。